Structural Biology of Human H3K9 Methyltransferases
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
UNLABELLED: SET domain methyltransferases deposit methyl marks on specific histone tail lysine residues and play a major role in epigenetic regulation of gene transcription. We solved the structures of the catalytic domains of GLP, G9a, Suv39H2 and PRDM2, four of the eight known human H3K9 methyltransferases in their apo conformation or in complex with the methyl donating cofactor, and peptide substrates. We analyzed the structural determinants for methylation state specificity, and designed a G9a mutant able to tri-methylate H3K9. We show that the I-SET domain acts as a rigid docking platform, while induced-fit of the Post-SET domain is necessary to achieve a catalytically competent conformation. We also propose a model where long-range electrostatics bring enzyme and histone substrate together, while the presence of an arginine upstream of the target lysine is critical for binding and specificity. ENHANCED VERSION: This article can also be viewed as an enhanced version in which the text of the article is integrated with interactive 3D representations and animated transitions. Please note that a web plugin is required to access this enhanced functionality. Instructions for the installation and use of the web plugin are available in Text S1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Phylogenetic tree of human histone methyltransferases. Phylogeny is based on a multiple sequence alignment of the methyltransferase domain including the N-SET, Pre_SET, SET, I-SET, and Post-SET motifs. Substrate selectivity was extracted from Kouzarides [1]. Enzymes with solved structure are highlighted by a frame, dotted if no peptide substrate complex is available. Structures solved in the present work are framed in red.](https://figures.cochat.ai/paper-figures/f223740273dd4504943d435b9d71af7c/structural-biology-of-human-h3k9-methyltransferases-figure-1.jpg)

![Figure 3 Structural determinants of G9a mono/di-methylation specificity. A model of substrate lysine-bound G9a (Top panel) was generated from the superposition of the active sites of the GPL ternary complex and GLP. Y1067 of G9a stabilizes the di-methylamine end of the substrate lysine in an orientation where the lone-pair is not facing the co-factor, thereby disfavoring transfer of a third methyl group. The Y1067F mutant loses this restriction and can tri-methylate its substrate, as indicated in the table. Previous work had shown that the F1152Y G9a mutant can only mono-methylate H3K9 [29].](https://figures.cochat.ai/paper-figures/ecf8fd2d2aa84552bf80a968a979ba0d/structural-biology-of-human-h3k9-methyltransferases-figure-3.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sheldrick, G. M. (2008) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767307043930 · Cited by 87,804 · cited 1×
“PRDM2 structure was solved by single-wavelength anomalous diffraction (SAD) at low resolution, using a selenomethionine derivative crystal with the program SHELXD [37], and the phasing was performed using SHELXE [38].”
MethodCoot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571 · cited 2×
“Graphics program COOT [36] was used for model building and PLoS ONE | www.plosone.org 7 January 2010 | Volume 5 | Issue 1 | e8570 T a b le 1 .”
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
Bannister, A. J., Zegerman, P., Partridge, J. F., Miska, E. A., Thomas, J. O., Allshire, R. C., & Kouzarides, T. (2001) · Nature · doi:10.1038/35065138 · Cited by 2,903 · cited 1×
“. Tri-methylation of lysine 9 of histone 3 (H3K9) mediates chromatin recruitment of HP1, heterochromatin condensation and gene silencing”
BackgroundMethylation of histone H3 lysine 9 creates a binding site for HP1 proteins
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., & Jenuwein, T. (2001) · Nature · doi:10.1038/35065132 · Cited by 2,868
The diverse functions of histone lysine methylation
Martin, C., & Zhang, Y. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1761 · Cited by 2,057 · cited 2×
“Methylation of histone tails is one of the fundamental events of epigenetic signaling [3].”
BackgroundSubstructure solution with SHELXD
Schneider, T. R., & Sheldrick, G. M. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902011678 · Cited by 1,588 · cited 1×
“PRDM2 structure was solved by single-wavelength anomalous diffraction (SAD) at low resolution, using a selenomethionine derivative crystal with the program SHELXD [37], and the phasing was performed using SHELXE [38].”
MethodPartitioning and Plasticity of Repressive Histone Methylation States in Mammalian Chromatin
Peters, A. H. F. M., Kubicek, S., Mechtler, K., O'Sullivan, R. J., Derijck, A. A. H. A., Perez-Burgos, L., Kohlmaier, A., Opravil, S., Tachibana, M., Shinkai, Y., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00477-5 · Cited by 1,152 · cited 1×
“The specificity of PRDM2 is unknown [25].”
Heterochromatin and Epigenetic Control of Gene Expression
Grewal, S. I. S., & Moazed, D. (2003) · Science · doi:10.1126/science.1086887 · Cited by 1,065 · cited 1×
“Post-translational modifications of histone proteins regulate chromatin compaction, mediate epigenetic regulation of transcription, and control cellular differentiation in health and disease [1,2].”
BackgroundThe SET-domain protein superfamily: protein lysine methyltransferases.
Dillon, S. C., Zhang, X. Y., Trievel, R. C., & Cheng, X. (2005) · Genome biology · doi:10.1186/gb-2005-6-8-227 · Cited by 978 · cited 1×
“HKMTs catalyze the transfer of a methyl group from the co-factor S-adenosyl-Lmethionine (SAM) to a substrate lysine and, with the exception of DOT1L, are all organized around a canonical SET domain [7,8].”
Background
Cited by
Sneeringer, C. J., Scott, M. P., Kuntz, K. W., Knutson, S. K., Pollock, R. M., Richon, V. M., & Copeland, R. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012525107 · Cited by 683
“Similarly, the wild-type enzyme G9a can dimethylate H3K9 but is unable to perform the di- to trimethylation reaction.”
BackgroundInfluentialYap, D. B., Chu, J., Berg, T., Schapira, M., Cheng, S.-W. G., Moradian, A., Morin, R. D., Mungall, A. J., Meissner, B., Boyle, M., et al. (2011) · Blood · doi:10.1182/blood-2010-11-321208 · Cited by 606
“Biotinylated peptides, H3 (1-21) (#12-403), H3 (21-44) (#12-404), H3(21-44)K27(me1) (#12-567), H3(21-44)K27(me2) (#12566), and H3(21-44)K27(me3) (#12-565), were purchased from Upstate Biotechnology.”
Self-citationPadeken, J., Methot, S. P., & Gasser, S. M. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00483-w · Cited by 514
McCabe, M. T., Graves, A. P., Ganji, G., Diaz, E., Halsey, W. S., Jiang, Y., Smitheman, K. N., Ott, H. M., Pappalardi, M. B., Allen, K. E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116418109 · Cited by 483
“Similarly, exchange of the Y641 equivalent in the H3K9 methyltransferase G9a (Y1067) for phenylalanine converts the enzyme from a mono- and dimethyltransferase to a trimethyltransferase (38).”
BackgroundStruck, A., Thompson, M. L., Wong, L. S., & Micklefield, J. (2012) · ChemBioChem · doi:10.1002/cbic.201200556 · Cited by 430
Verma, S. K., Tian, X., LaFrance, L. V., Duquenne, C., Suarez, D. P., Newlander, K. A., Romeril, S. P., Burgess, J. L., Grant, S. W., Brackley, J. A., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml3003346 · Cited by 371
SRA- and SET-domain-containing proteins link RNA polymerase V occupancy to DNA methylation
Johnson, L. M., Du, J., Hale, C. J., Bischof, S., Feng, S., Chodavarapu, R. K., Zhong, X., Marson, G., Pellegrini, M., Segal, D. J., et al. (2014) · Nature · doi:10.1038/nature12931 · Cited by 332
Mutations in EZH2 Cause Weaver Syndrome
Gibson, W. T., Hood, R. L., Zhan, S. H., Bulman, D. E., Fejes, A. P., Moore, R., Mungall, A. J., Eydoux, P., Babul-Hirji, R., An, J., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.11.018 · Cited by 321
“6 Å]; see Figure 4).(25) The conformation of this conserved histidine is highly similar across known crystal structures for the SET domain.”
BackgroundChemical and Biochemical Perspectives of Protein Lysine Methylation
Luo, M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00008 · Cited by 284
Discovery of an in Vivo Chemical Probe of the Lysine Methyltransferases G9a and GLP
Liu, F., Barsyte-Lovejoy, D., Li, F., Xiong, Y., Korboukh, V., Huang, X.-P., Allali-Hassani, A., Janzen, W. P., Roth, B. L., Frye, S. V., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401480r · Cited by 268
Self-citationThe prdm family: expanding roles in stem cells and development
Hohenauer, T., & Moore, A. W. (2012) · Development · doi:10.1242/dev.070110 · Cited by 265
EZH2: biology, disease, and structure-based drug discovery
Tan, J.-Z., Yan, Y., Wang, X.-X., Jiang, Y., & Xu, H. E. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.161 · Cited by 234
Role of the Polycomb Repressive Complex 2 (PRC2) in Transcriptional Regulation and Cancer
Laugesen, A., Højfeldt, J. W., & Helin, K. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026575 · Cited by 214
Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer
Dong, C., Wu, Y., Wang, Y., Wang, C., Kang, T., Rychahou, P. G., Chi, Y.-I., Evers, B. M., & Zhou, B. P. (2013) · Oncogene · doi:10.1038/onc.2012.169 · Cited by 214
The Bioinorganic Chemistry of Mammalian Metallothioneins
Krężel, A., & Maret, W. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00371 · Cited by 207
Structural Basis of Substrate Methylation and Inhibition of SMYD2
Ferguson, A. D., Larsen, N. A., Howard, T., Pollard, H., Green, I., Grande, C., Cheung, T., Garcia-Arenas, R., Cowen, S., Wu, J., et al. (2011) · Structure · doi:10.1016/j.str.2011.06.011 · Cited by 203
“A similar series of electrostatic interactions between protein lysine methyltransferases with their respective substrates have been structurally observed (reviewed by Cheng et al., 2005; Wu et al., 2010).”
BackgroundInfluentialPRDM proteins: important players in differentiation and disease
Fog, C. K., Galli, G. G., & Lund, A. H. (2012) · BioEssays · doi:10.1002/bies.201100107 · Cited by 201
“Moreover, the crystal structure of PRDM2 revealed that the two domains are also structurally similar, both being able to accommodate the co-factor S-adenosyl-methionine [2].”
BackgroundChemogenetic Analysis of Human Protein Methyltransferases
Richon, V. M., Johnston, D., Sneeringer, C. J., Jin, L., Majer, C. R., Elliston, K., Jerva, L. F., Scott, M. P., & Copeland, R. A. (2011) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2011.01135.x · Cited by 188
The Structure of NSD1 Reveals an Autoregulatory Mechanism Underlying Histone H3K36 Methylation
Qiao, Q., Li, Y., Chen, Z., Wang, M., Reinberg, D., & Xu, R.-M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.204115 · Cited by 170
G9a, a multipotent regulator of gene expression
Shankar, S. R., Bahirvani, A. G., Rao, V. K., Bharathy, N., Ow, J. R., & Taneja, R. (2013) · Epigenetics · doi:10.4161/epi.23331 · Cited by 169
“Apart from these positional preferences, modification of H3 proximal amino acids serine groove is formed by I-SET and post-SET domains.(13) When transiently expressed, G9a and GLP form homomeric and heteromeric complexes via their SET domain; however, endogenously they function exclusively as a heteromeric complex in…”
BackgroundChang, Y., Sun, L., Kokura, K., Horton, J. R., Fukuda, M., Espejo, A., Izumi, V., Koomen, J. M., Bedford, M. T., Zhang, X., et al. (2011) · Nature Communications · doi:10.1038/ncomms1549 · Cited by 160
“The Dnmt3a peptide conformation is nearly identical with that of histone H3 peptide bound with GLP SET domai”
BackgroundSinefungin Derivatives as Inhibitors and Structure Probes of Protein Lysine Methyltransferase SETD2
Zheng, W., Ibáñez, G., Wu, H., Blum, G., Zeng, H., Dong, A., Li, F., Hajian, T., Allali-Hassani, A., Amaya, M. F., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja307060p · Cited by 151
Self-citationGibaja, V, Shen, F., Harari, J., Korn, J., Ruddy, D., Saenz-Vash, V, Zhai, H., Rejtar, T., Paris, C. G., Yu, Z., et al. (2016) · Oncogene · doi:10.1038/onc.2015.114 · Cited by 149
Wu, H., Zeng, H., Dong, A., Li, F., He, H., Senisterra, G., Seitova, A., Duan, S., Brown, P. J., Vedadi, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083737 · Cited by 140
“Finally, autoinhibitory conformations where the post-SET domain occludes the substrate binding groove were reported for the H3K36 methyltransferases SETD2, SETMAR and NSD1 and the H3K9 methyltransferase SUV39H2 ([43,59,60] and PDB code 3BO5).”
BackgroundInfluentialSelf-citationAl-Sady, B., Madhani, H. D., & Narlikar, G. J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.06.013 · Cited by 143
“The ability of Suv39/Clr4 to produce all three methylation states is in part predicted from sequence homology of key active site residues to those of other H3K9me writers (Couture et al., 2008; Wu et al., 2010) and has been qualitatively demonstrated on peptide substrates (Dirk et al., 2007).”
Diverse involvement of EZH2 in cancer epigenetics.
Völkel, P., Dupret, B., Bourhis, X. L., & Angrand, P. (2015) · PubMed · Cited by 174
Understanding the interplay between CpG island-associated gene promoters and H3K4 methylation
Hughes, A. L., Kelley, J. R., & Klose, R. J. (2020) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2020.194567 · Cited by 139
S-Adenosyl Methionine and Transmethylation Pathways in Neuropsychiatric Diseases Throughout Life
Gao, J., Cahill, C. M., Huang, X., Roffman, J. L., Lamon‐Fava, S., Fava, M., Mischoulon, D., & Rogers, J. T. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0593-0 · Cited by 152
Engaging chromatin: PRC2 structure meets function
Chammas, P., Mocavini, I., & Croce, L. D. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0615-2 · Cited by 154
Bhlhb5 and Prdm8 form a repressor complex involved in neuronal circuit assembly
Ross, S. E., McCord, A. E., Jung, C., Atan, D., Mok, S. I., Hemberg, M., Kim, T.-K., Salogiannis, J., Hu, L., Cohen, S., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.09.035 · Cited by 137
“…including Prdm8, have been reported to have intrinsic histone methyltransferase activity (Eom et al., 2009; Hayashi et al., 2005; Kim et al., 2003; Wu et al., 2010), while others are known to function as repressors by recruiting histone modifying enzymes (Ancelin et al., 2006; Davis et al., 2006;…”
BackgroundCancers and the NSD family of histone lysine methyltransferases
Morishita, M., & di Luccio, E. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.05.004 · Cited by 132
Adding a Lysine Mimic in the Design of Potent Inhibitors of Histone Lysine Methyltransferases
Chang, Y., Ganesh, T., Horton, J. R., Spannhoff, A., Liu, J., Sun, A., Zhang, X., Bedford, M. T., Shinkai, Y., Snyder, J. P., et al. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.04.048 · Cited by 134
Structure, Activity, and Function of PRMT1
Thiébaut, C., Eve, L., Poulard, C., & Romancer, M. L. (2021) · Life · doi:10.3390/life11111147 · Cited by 120
“Phylogenetic studies based on the methyltransferase domain highlighted that PRMT1 is closely related to PRMT8 [7].”
BackgroundHickok, J. R., Vasudevan, D., Antholine, W. E., & Thomas, D. D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.432294 · Cited by 118
Shinsky, S. A., Monteith, K. E., Viggiano, S., & Cosgrove, M. S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.627646 · Cited by 120
“Phylogenetic analysis shows that the human SET1 family reduces to three distinct clades with MLL1 and MLL4 (also known as MLL2, Wbp7, KMT2B) being most closely related to Trx, MLL2 (MLL4, ALR, KMT2D) and MLL3 (KMT2C) being most closely related to Trr, and Setd1A and Setd1B being most closely related to Drosophila dSET…”
BackgroundSe-Adenosyl- l -selenomethionine Cofactor Analogue as a Reporter of Protein Methylation
Bothwell, I. R., Islam, K., Chen, Y., Zheng, W., Blum, G., Deng, H., & Luo, M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja304782r · Cited by 111
A two-state activation mechanism controls the histone methyltransferase Suv39h1
Müller, M. M., Fierz, B., Bittova, L., Liszczak, G., & Muir, T. W. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2008 · Cited by 130
The CW domain, a new histone recognition module in chromatin proteins
Hoppmann, V., Thorstensen, T., Kristiansen, P. E., Veiseth, S. V., Rahman, M. A., Finne, K., Aalen, R. B., & Aasland, R. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.108 · Cited by 108
“…is conferred by SET-domain proteins that can be divided into several evolutionarily conserved classes (Baumbusch et al, 2001; Kouzarides, 2007; Wu et al, 2010) including: (1) the E(z) class, involved in the maintenance of a transcriptionally repressive state of genes via H3K27…”
BackgroundExpanding Cofactor Repertoire of Protein Lysine Methyltransferase for Substrate Labeling
Islam, K., Zheng, W., Yu, H., Deng, H., & Luo, M. (2011) · ACS Chemical Biology · doi:10.1021/cb2000567 · Cited by 110
“Alanine mutations of Y1067 and F1152 mutants showed the processivity to trimethylated product (Figures 2a, S3,6), consistent with their roles as mono-/di-/trimethylation switches (14, 32).”
BackgroundBioorthogonal Profiling of Protein Methylation Using Azido Derivative of S -Adenosyl- l -methionine
Islam, K., Bothwell, I. R., Chen, Y., Sengelaub, C. A., Wang, R. Y., Deng, H., & Luo, M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2118333 · Cited by 125
Antonysamy, S., Condon, B., Druzina, Z., Bonanno, J. B., Gheyi, T., Zhang, F., MacEwan, I., Zhang, A., Ashok, S., Rodgers, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084147 · Cited by 104
“We determined the crystal structure of the isolated EZH2 SET domain in order to compare and contrast it with the crystal structure of other SET domains [50], better understand the structural context of clinically relevant EZH2 mutations, and to possibly elucidate autoregulatory mechanisms of EZH2 methyltransferase act…”
BackgroundResultInfluentialStructural Chemistry of Human SET Domain Protein Methyltransferases
Schapira, M. (2011) · Current Chemical Genomics · doi:10.2174/1875397301005010085 · Cited by 120
“This is in part confirmed by the selectivity profile of UNC0638 an inhibitor that specifically inhibit the H3K9 PMTs G9a and GLP, but not the H3K4 PMT SETD7, the H4K20 PMT SETD8, or even the H3K9 PMT SUV39H2 [40]).”
BackgroundInfluentialSelf-citationThe role of PRDMs in cancer: one family, two sides
Mzoughi, S., Tan, Y. X., Low, D. H. P., & Guccione, E. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.03.009 · Cited by 115
An Allosteric Inhibitor of Protein Arginine Methyltransferase 3
Siarheyeva, A., Senisterra, G. A., Allali‐Hassani, A., Dong, A., Dobrovetsky, E., Wasney, G. A., Chau, I., Marcellus, R. C., Hajian, T., Liu, F., et al. (2012) · Structure · doi:10.1016/j.str.2012.06.001 · Cited by 102
“The wild-type PRMT3 gene (amino acids 211–531) was cloned into the pET28a-LIC vector (GenBank EF442785), expressed and purified as previously reported (Wu et al., 2010).”
MethodSelf-citationDysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN
Nakakido, M., Deng, Z., Suzuki, T., Dohmae, N., Nakamura, Y., & Hamamoto, R. (2015) · Neoplasia · doi:10.1016/j.neo.2015.03.002 · Cited by 100
“Recent structural and biochemical analyses suggested some consensus sequences for other methyltransferases, SET7/9 and SUV39H2 [44,45], but any consensus sequence has not been indicated for SMYD2.”
BackgroundCovalent inhibition of NSD1 histone methyltransferase
Huang, H., Howard, C. A., Zari, S., Cho, H. J., Shukla, S., Li, H., Ndoj, J., Gónzález-Alonso, P., Nikolaidis, C., Abbott, J. M., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0626-6 · Cited by 95
Jayaram, H., Hoelper, D., Jain, S. U., Cantone, N., Lundgren, S. M., Poy, F., Allis, C. D., Cummings, R., Bellon, S., & Lewis, P. W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605523113 · Cited by 92
“These data are consistent with a proposed model where SAM facilitates folding of the G9a postSET domain, which forms part of the peptide binding site for H3K9 (18).”
ResultInner workings and regulatory inputs that control Polycomb repressive complex 2
O’Meara, M., & Simon, J. A. (2012) · Chromosoma · doi:10.1007/s00412-012-0361-1 · Cited by 112
The Y641C mutation of EZH2 alters substrate specificity for histone H3 lysine 27 methylation states
Wigle, T. J., Knutson, S. K., Jin, L., Kuntz, K. W., Pollock, R. M., Richon, V. M., Copeland, R. A., & Scott, M. P. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.018 · Cited by 91
“This is consistent with the concept that EZH2 Y641 mutations [2], and analogous SET domain mutations shown in SET7/9 [18] and G9a [19], alleviate steric crowding of the target lysine in the active site.”
BackgroundEvolving Catalytic Properties of the MLL Family SET Domain
Zhang, Y., Mittal, A., Reid, J., Reich, S., Gamblin, S. J., & Wilson, J. R. (2015) · Structure · doi:10.1016/j.str.2015.07.018 · Cited by 90
Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming
Torrano, J., Emran, A. A., Hammerlindl, H., & Schaider, H. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0644-y · Cited by 95
Protein Methyltransferases: A Distinct, Diverse, and Dynamic Family of Enzymes
Boriack‐Sjodin, P. A., & Swinger, K. K. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b01129 · Cited by 96
Molecular basis for the role of oncogenic histone mutations in modulating H3K36 methylation
Zhang, Y., Shan, C., Wang, J., Bao, K., Tong, L., & Jia, S. (2017) · Scientific Reports · doi:10.1038/srep43906 · Cited by 91
“1d) 25 .”
Structural Chemistry of the Histone Methyltransferases Cofactor Binding Site
Campágna‐Slater, V., Mok, M. W., Nguyen, K. T., Fehér, M., Najmanovich, R., & Schapira, M. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci100479z · Cited by 86
Self-citationDefining efficient enzyme–cofactor pairs for bioorthogonal profiling of protein methylation
Islam, K., Chen, Y., Wu, H., Bothwell, I. R., Blum, G., Zeng, H., Dong, A., Zheng, W., Min, J., Deng, H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216365110 · Cited by 92
“Given that the C-terminal catalytic domains of EuHMT1/2, although active (15, 28, 36), show less optimal activity (13), we reasoned that one merit of the BPPM approach lies in its ability to implement full-length enzymes to profile their activities.”
BackgroundSelf-citationDiscovery of Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine Methyltransferase
Xiong, Y., Li, F., Babault, N., Dong, A., Zeng, H., Wu, H., Chen, X., Arrowsmith, C. H., Brown, P. J., Liu, J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01645 · Cited by 81
Self-citationStructural basis of SETD6-mediated regulation of the NF-kB network via methyl-lysine signaling
Chang, Y., Levy, D., Horton, J. R., Peng, J., Zhang, X., Gozani, O., & Cheng, X. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr256 · Cited by 77
“Encouraged by the known structures of (i) the RelA/p50 heterodimer bound to DNA (23), (ii) the RelA/p50 heterodimer bound to IkB (24) and (iii) the GLP ankyrin repeat domain (10) and SET domain of GLP bound with H3 peptide (25), we modeled a quaternary complex involving DNA, NF-kB (RelA/p50), and GLP (ankyrin repeats…”
BackgroundBinda, O., LeRoy, G., Bua, D. J., Garcia, B. A., Gozani, O., & Richard, S. (2010) · Epigenetics · doi:10.4161/epi.5.8.13278 · Cited by 96
Molecular Recognition of Lys and Arg Methylation
Beaver, J. E., & Waters, M. L. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00996 · Cited by 86
On your histone mark, SET, methylate!
Binda, O. (2013) · Epigenetics · doi:10.4161/epi.24451 · Cited by 92
Han, P., Li, W., Yang, J., Shang, C., Lin, C.-H., Cheng, W. N., Hang, C. T., Cheng, H.-L., Chen, C.-H., Wong, J., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.03.002 · Cited by 76
“By RT–qPCR, we examined the expression of known histone H3K9 methyltransferases (H3K9MTs) [32]—G9a/Ehmt2, Glp/Ehmt1, Suv39h1, Suv39h2, Setdb1, and Setdb2 (Supplemental Text)—in mouse heart ventricles with or without TAC by normalization to TFIIb [25].”
MethodGain-of-Function Genetic Alterations of G9a Drive Oncogenesis
Kato, S., Weng, Q. Y., Insco, M. L., Chen, K. Y., Muralidhar, S., Poźniak, J., Diaz, J. M. S., Drier, Y., Nguyen, N. T., Lo, J. A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0532 · Cited by 79
“G1069 is located adjacent to the histone binding pocket and probably does not physically interact with the histone tail, as shown in a study using structural model analysis of H3K9 HMTs (41).”
BackgroundAutomethylation-induced conformational switch in Clr4 (Suv39h) maintains epigenetic stability
Iglesias, N., Currie, M. A., Jih, G. T., Paulo, J. A., Siuti, N., Kalocsay, M., Gygi, S. P., & Moazed, D. (2018) · Nature · doi:10.1038/s41586-018-0398-2 · Cited by 83
Xu, S., Wu, J., Sun, B., Zhong, C., & Ding, J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr019 · Cited by 78
“Comparison of Smyd3 with the other methyltransferases containing a Cysteine-rich post-SET domain such as MLL1 (29), Dim5 (22,38) and Suv39H2 (17) shows that the position and coordination of the bound Zn2+ in these enzymes are similar; however, the overall structures of the post-SET domains are quite different: the pos…”
BackgroundAndreoli, F., Barbosa, A. J. M., Parenti, M. D., & Río, A. D. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804581918 · Cited by 68
Crystal structures of the human histone H4K20 methyltransferases SUV420H1 and SUV420H2
Wu, H., Siarheyeva, A., Zeng, H., Lam, R., Dong, A., Wu, X., Li, Y., Schapira, M., Vedadi, M., & Min, J. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.10.020 · Cited by 66
“Our effort to generate crystals of SUV420H1 and SUV420H2 in complex with a substrate was not successful, but when we superimposed the crystal structures of SUV420H1 and SUV420H2 with the complex structure of GLP-H3K9me2 peptide [56], we found that, like GLP, SUV420H1 and SUV420H2 harbor an aromatic pocket, which presu…”
BackgroundSelf-citationIn vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L
Morishita, M., Mevius, D. E. H. F., & di Luccio, E. (2014) · BMC Structural Biology · doi:10.1186/preaccept-3867013771372917 · Cited by 66
Milite, C., Feoli, A., Horton, J. R., Rescigno, D., Cipriano, A., Pisapia, V., Viviano, M., Pepe, G., Amendola, G., Novellino, E., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b02008 · Cited by 66
Roquis, D., Taudt, A., Geyer, K. K., Padalino, G., Hoffmann, K. F., Holroyd, N. E., Berriman, M., Aliaga, B., Chaparro, C., Grunau, C., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007066 · Cited by 65
Theillet, F., Liokatis, S., Jost, J. O., Bekei, B., Rose, H. M., Binolfi, A., Schwarzer, D., & Selenko, P. (2012) · Journal of the American Chemical Society · doi:10.1021/ja301895f · Cited by 62
Writing and Reading Histone H3 Lysine 9 Methylation in Arabidopsis
Xu, L., & Jiang, H. L. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.00452 · Cited by 69
Targets in Epigenetics: Inhibiting the Methyl Writers of the Histone Code
Yost, J. M., Korboukh, I., Liu, F., Gao, C., & Jin, J. (2011) · Current Chemical Genomics · doi:10.2174/1875397301005010072 · Cited by 61
Cheedipudi, S. M., Puri, D., Saleh, A., Gala, H., Rumman, M., Pillai, M. S., Sreenivas, P., Arora, R., Sellathurai, J., Schrøder, H. D., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv567 · Cited by 62
“Although the methyltransferase activity of PRDM2 is well established (38,72) and the crystal structure of its SET domain determined (73), the specificity for histone methylation state has not been unambiguously established.”
BackgroundTrimethyllysine: From Carnitine Biosynthesis to Epigenetics
Maas, M. N., Hintzen, J. C. J., Porzberg, M. R. B., & Mecinović, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249451 · Cited by 62
“SUV39H2 catalyzes di- and trimethylation of H3K9, and it is structurally very similar to G9a and GLP, which catalyze mono-, di-, and trimethylation on the same K [58].”
BackgroundSun, L., & Fang, J. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.04.022 · Cited by 59
“It has been shown that SET-Insertion varies in sequence across different HMTases but appears relatively conserved in the structure and acts as a substrate docking platform (Wu et al., 2010; Xiao et al., 2003).”
Chen, D., Li, L., Diaz, K., Iyamu, I. D., Yadav, R., Noinaj, N., & Huang, R. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01255 · Cited by 54
Methyltransferase Inhibitors: Competing with, or Exploiting the Bound Cofactor
de Freitas, R. F., Ivanochko, D., & Schapira, M. (2019) · Molecules · doi:10.3390/molecules24244492 · Cited by 60
“Potent inhibitors have been reported for both SET domain (EZH2, EHMT1/2, SMYD2, SMYD3, SUV420H1/2, SETD7) and Class I (DOT1L, PRMT5, PRMT1/8, PRMT3, PRMT4, PRMT6) enzymes [1,7], but some PMTs with strong disease association remain so far without high-quality drug-like ligands: recurrent chromosomal aberrations affecti…”
BackgroundSelf-citationStructure, Activity, and Function of the Protein Lysine Methyltransferase G9a
Poulard, C., Noureddine, L. M., Pruvost, L., & Romancer, M. L. (2021) · Life · doi:10.3390/life11101082 · Cited by 65
Activity and specificity of the human SUV39H2 protein lysine methyltransferase
Schuhmacher, M. K., Kudithipudi, S., Kušević, D., Weirich, S., & Jeltsch, A. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.11.005 · Cited by 59
Clough, E., Tedeschi, T. R., & Hazelrigg, T. I. (2014) · Developmental Biology · doi:10.1016/j.ydbio.2014.01.014 · Cited by 57
“The weak eggA97 mutation (E1079K) lies at the border of the SET-I domain, a region that may affect substrate specificity (Zhang et al., 2002; Wu et al., 2010).”
Candelaria, M., la Cruz-Hernández, E. N. D., Taja‐Chayeb, L., Pérez‐Cárdenas, E., Trejo‐Becerril, C., González‐Fierro, A., Chávez-Blanco, A. D., Soto‐Reyes, E., Domínguez-Gómez, G., Trujillo, J. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029181 · Cited by 53
“aza-CdR in a breast cancer model of MASPIN re-expression where reductions in G9A histone methyltransferase protein levels are not due to effects on G9A gene expression [53].”
BackgroundStructure, Activity and Function of the Suv39h1 and Suv39h2 Protein Lysine Methyltransferases
Weirich, S., Khella, M. S., & Jeltsch, A. (2021) · Life · doi:10.3390/life11070703 · Cited by 64
“Similar to G9a [27] and SUV39H2 (see below) [28], SUV39H1 shows a high specificity for an arginine at the −1 position (R8) (using K9 as reference position), replacing this R by any other amino acid completely abolished the catalytic activity.”
BackgroundInfluentialEpigenetic targets and drug discovery
Liu, Y., Liu, K., Su, Q., Xu, C., & Min, J. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.03.007 · Cited by 53
“Biochemically, both G9a and GLP could form homodimer via their catalytic domain (Wu et al., 2010), however, G9 and GLP always exist as a stoichiometric G9a–GLP heteromeric complex when purified endogenously from different cells, and knockout of either of them causes severely reduced H3K9me1/2 levels in vivo (Shinkai &…”
Self-citationZuchegna, C., Aceto, F., Bertoni, A., Romano, A., Perillo, B., Laccetti, P., Gottesman, M. E., Avvedimento, E. V., & Porcellini, A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku823 · Cited by 51
“H3K9me2/3 accumulation at 30-min RA is associated with the recruitment of SUV39H1 (16) to the promoter, RARE and polyA addi- tion sites (Supplementary Figure S3a and b).”
BackgroundInfluentialCrawford, N., McIntyre, A. J., McCormick, A., D’Costa, Z., Buckley, N. E., & Mullan, P. B. (2019) · Oncogene · doi:10.1038/s41388-019-0853-z · Cited by 52
A687V EZH2 Is a Driver of Histone H3 Lysine 27 (H3K27) Hypertrimethylation
Ott, H. M., Graves, A. P., Pappalardi, M. B., Huddleston, M. J., Halsey, W. S., Hughes, A. M., Groy, A., Dul, E., Jiang, Y., Bai, Y., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0876 · Cited by 53
“Mutation of this restrictive tyrosine to a smaller residue converts these enzymes into efficient trimethyltransferases (19, 21, 22, 34, 35).”
Structure, Activity and Function of the SETDB1 Protein Methyltransferase
Markouli, M., Strepkos, D., & Piperi, C. (2021) · Life · doi:10.3390/life11080817 · Cited by 55
“The SET domain is arranged in a helix formation which is linked to an anti-parallel two-stranded β-sheet by loops of different lengths which consist of amino acids that intercept the bifurcated SET domain [16].”
BackgroundFluorescence-Based Methods for Screening Writers and Readers of Histone Methyl Marks
Allali‐Hassani, A., Wasney, G. A., Siarheyeva, A., Hajian, T., Arrowsmith, C. H., & Vedadi, M. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111422256 · Cited by 52
Self-citationWigle, T. J., Provencher, L. M., Norris, J. L., Jin, J. J., Brown, P. J., Frye, S. V., & Janzen, W. P. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.04.014 · Cited by 53
Chemical Inhibition of Protein Methyltransferases
Schapira, M. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.07.014 · Cited by 51
Self-citationLysine methyltransferase inhibitors: where we are now
Feoli, A., Viviano, M., Cipriano, A., Milite, C., Castellano, S., & Sbardella, G. (2022) · RSC Chemical Biology · doi:10.1039/d1cb00196e · Cited by 53
Targeting EHMT2/ G9a for cancer therapy: Progress and perspective
Jan, S., Dar, M. I., Wani, R., Sandey, J., Mushtaq, I., Lateef, S., & Syed, S. H. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173827 · Cited by 52
Identification and characterization of a nanog homolog in Japanese flounder (Paralichthys olivaceus)
Gao, J., Wang, J., Jiang, J., Fan, L., Wang, W., Liu, J., Zhang, Q., & Wang, X. (2013) · Gene · doi:10.1016/j.gene.2013.08.030 · Cited by 48
Fatty acid induced metabolic memory involves alterations in renal histone H3K36me2 and H3K27me3
Kumar, S., Pamulapati, H., & Tikoo, K. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.12.019 · Cited by 53
di Luccio, E. (2015) · Journal of Cancer Prevention · doi:10.15430/jcp.2015.20.2.113 · Cited by 48
“However, this is not observed in both H3K9 and H3K4-specific HMTases.(46-48) Therefore, we elected to model NSD2-SET in an opened conformation using long range MD simulations that we previously described for NSD1 (Fig.”
A histone H3K9M mutation traps histone methyltransferase Clr4 to prevent heterochromatin spreading
Shan, C., Wang, J., Xu, K., Chen, H., Yue, J., Andrews, S. J., Moresco, J. J., Yates, J. R., Nagy, P. L., Tong, L., et al. (2016) · eLife · doi:10.7554/elife.17903 · Cited by 49
“Compared with the structure of another H3K9 methyltransferase G9a-like protein 1 (GLP1) in complex with a dimethylated H3K9 peptide and SAH (Wu et al., 2010), the binding mode of the H3K9M peptide to G9a is essentially identical (Figure 4C and D).”
BackgroundMethodInfluentialTargeting epigenetic modifiers: Inhibitors of histone methyltransferases
Bissinger, E.-M., Heinke, R., Sippl, W., & Jung, M. (2010) · MedChemComm · doi:10.1039/c0md00062k · Cited by 48
Wang, R., Ibáñez, G., Islam, K., Zheng, W., Blum, G., Sengelaub, C. A., & Luo, M. (2011) · Molecular BioSystems · doi:10.1039/c1mb05230f · Cited by 44
Mauger, O., Klinck, R., Chabot, B., Muchardt, C., Allemand, E., & Batsché, É. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv013 · Cited by 46
“These HMTases cooperate in the control of the mono-, di-, or tri-methylation of histone H3 at lysine 9 (H3K9me1/2/3) (26,27), and these marks are generally associated with transcriptional silencing (28).”
BackgroundThe Oncogenic Potential of SUV39H2: A Comprehensive and Perspective View
Li, B., Zheng, Y., & Yang, L. (2019) · Journal of Cancer · doi:10.7150/jca.28254 · Cited by 45
“In humans, the SUV39 family proteins, namely SUV39H1 (KMT1A), SUV39H2 (KMT1B), SETDB1 (KMT1E), SETDB2 (KMT1F), G9A (EHMT2) and G9a-like protein (GLP1), contain pre-SET (N-SET) and post-SET (C-SET) domains besides the SET domain and mediate H3K9 methylation [3-6].”
Background
Metadata
- Authors
- Wu, H., Min, J., Lunin, V. V., Antoshenko, T., Dombrovski, L., Zeng, H., Allali-Hassani, A., Campagna-Slater, V., Vedadi, M., Arrowsmith, C. H., Plotnikov, A. N., & Schapira, M.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Plotnikov, Alexander N.
- Schapira, Matthieu
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-01-11
- Volume
- 5
- Issue
- 1
- Pages
- e8570
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2797608
- OpenAlex
- W2106473601
- Cited by
- 268
- References
- 39
- Citations by year
- 2026: 12 · 2025: 8 · 2024: 11 · 2023: 14 · 2022: 15 · 2021: 16 · 2020: 17 · 2019: 17 · 2018: 14 · 2017: 14 · 2016: 16 · 2015: 24 · 2014: 20 · 2013: 17 · 2012: 21
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- GlaxoSmithKline
- Ontario Innovation Trust
- Genome Canada (1097737)
- Wellcome Trust (1097737)
- Ontario Genomics
- Ontario Genomics Institute
- Stiftelsen för Strategisk Forskning
- Karolinska Institutet
- Knut och Alice Wallenbergs Stiftelse
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- H3K9 methyltransferase, SET domain, G9a, GLP, SUV39H2, PRDM2, histone methylation, epigenetic regulation, S-adenosylmethionine, induced fit, electrostatic interactions, protein structure
- MeSH terms
- Histone Methyltransferases, Crystallization, Humans, Models, Molecular, Protein Conformation, Histone-Lysine N-Methyltransferase, Substrate Specificity, Catalytic Domain, Static Electricity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.